Changes in Beneficial Ownership · 4
Bausch Health Companies Inc
Changes in Beneficial Ownership
Structured filing — 4
form4.xml
Filing details
- Report period
- 2026-06-30
- Issuer
- Bausch Health Companies Inc.
- Issuer CIK
- 0000885590
- Trading symbol
- BHC
Reporting owner 1
- Name
- LEUNG SANDRA
- Reporting owner CIK
- 0001199294
- Relationship
- Director
- Address
- 400 SOMERSET CORPORATE BLVD., BRIDGEWATER, NJ, 08807
Non-derivative transactions
| Security | Transaction date | Code | Amount | A / D | Price (USD) | Owned after | Ownership |
|---|---|---|---|---|---|---|---|
| Common Shares, No Par Value | 2026-06-30 | A · Form 4 | 6,845[F1] | A | 4.93 | 97,070 | D |
Table key
- A · Form 4
- Acquisition by grant, award or otherwise under Rule 16b-3(d)
- A
- Acquired
- D
- Direct
Footnotes
- F1
- Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending June 30, 2026, each representing a contingent right to receive one common share, no par value, of the Issuer.↩ 1
Signature 1
- Signed
- /s/ Brianna M. Dorsi, attorney-in-fact
- Date
- 2026-07-02
Company context
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is a global, diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neuroscience, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb Corporation. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. For more information about Bausch Health, visit www.bauschhealth.com and connect with us on LinkedIn.